{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:02:26Z","timestamp":1747800146101,"version":"3.41.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,19]]},"DOI":"10.7759\/cureus.84442","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:50:56Z","timestamp":1747731056000},"source":"Crossref","is-referenced-by-count":0,"title":["Complete Resolution of New Daily Persistent Headache With Migraine-Like Features Following Erenumab Treatment: A Case Report"],"prefix":"10.7759","author":[{"given":"Shoji","family":"Kikui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Danno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13103","article-title":"New daily persistent headache: historical review and an interview with Dr. Walter Vanast","volume":"57","author":"Robbins MS","year":"2017","unstructured":"Robbins MS, Vanast WJ, Purdy RA. New daily persistent headache: historical review and an interview with Dr. Walter Vanast. Headache. 2017, 57:926-34. 10.1111\/head.13103","journal-title":"Headache"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38.1-211. 10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.01872.x","article-title":"New daily persistent headache: a syndrome not a discrete disorder","volume":"51","author":"Goadsby PJ","year":"2011","unstructured":"Goadsby PJ. New daily persistent headache: a syndrome not a discrete disorder. Headache. 2011, 51:650-3. 10.1111\/j.1526-4610.2011.01872.x","journal-title":"Headache"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/head.13624","article-title":"The three T's of NDPH (how clinical observations have led to improved treatment outcomes)","volume":"59","author":"Rozen TD","year":"2019","unstructured":"Rozen TD. The three T's of NDPH (how clinical observations have led to improved treatment outcomes). Headache. 2019, 59:1401-6. 10.1111\/head.13624","journal-title":"Headache"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/25158163231195769","article-title":"Case report: monoclonal antibodies as an alternative treatment for new daily persistent headache","volume":"6","author":"Bancalari EM","year":"2023","unstructured":"Bancalari EM, Hern\u00e1ndez N, Soria A, Bruera O. Case report: monoclonal antibodies as an alternative treatment for new daily persistent headache. Cephalalgia Rep. 2023, 6:10.1177\/25158163231195769","journal-title":"Cephalalgia Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231182126","article-title":"Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: new daily persistent headache or persistent post-traumatic headache in the majority of cases","volume":"43","author":"Buture A","year":"2023","unstructured":"Buture A, Tomkins EM, Shukralla A, et al.. Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: new daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia. 2023, 43:3331024231182126. 10.1177\/03331024231182126","journal-title":"Cephalalgia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370459-complete-resolution-of-new-daily-persistent-headache-with-migraine-like-features-following-erenumab-treatment-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:50:58Z","timestamp":1747731058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370459-complete-resolution-of-new-daily-persistent-headache-with-migraine-like-features-following-erenumab-treatment-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.84442","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}